-
Bristol to acquire Amira
NEW YORK — Bristol-Myers Squibb will acquire San Diego-based Amira Pharmaceuticals for $325 million, the two companies said Friday.
Amira develops pharmaceutical drugs for treating inflammatory and fibrotic diseases, and the deal includes milestone payments of up to $150 million on top of the upfront purchase price. Amira’s drugs include AM152, an investigational treatment for idiopathic pulmonary fibrosis, currently in early-stage clinical trials and set to enter mid-stage trials.
-
Safeway sees sales, income boost in Q2
PLEASANTON, Calif. — Safeway reported net income of $145.8 million, or 41 cents per diluted share, for second quarter 2011, compared with $141.3 million, or 37 cents per diluted share, during the year-ago period.
The company reported that total sales increased 7.1% to $10.2 billion in second quarter 2011 from $9.5 billion in second quarter 2010. Identical-store sales, excluding fuel, saw a 0.5% increase.